Atmus Filtration Technologies Inc.
ATMU NYSE Motor Vehicle Parts & Accessories Financials FY2021βFY2025
What Atmus Filtration Technologies Inc. does
No business description yet.
- Legal name
- Atmus Filtration Technologies Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 13, 2026
- Accession Β· CIK
- 0001921963-26-000015
0001921963
Revenue and margins
Atmus Filtration Technologies Inc. had $1.8B of revenue in fiscal 2025, up 5.7% on the year before.
Net income and earnings per share
From fiscal 2021 to 2025, diluted EPS grew 5.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $149M in fiscal 2025, 8.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Atmus Filtration Technologies Inc. returned $60.7M to shareholders in fiscal 2025, 41% of free cash flow. The diluted share count fell 1.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Atmus Filtration Technologies Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $0.0M | $0.0M | $168M | $184M | $236M |
| Debt incl. finance leases | β | $0.0M | $601M | $594M | $572M |
| Net debt / EBITDA | β | 0.0x | 1.6x | 1.4x | 1.0x |
| Debt / equity | β | 0.0x | 7.4x | 2.6x | 1.5x |
| Interest coverage | 266.9x | 291.3x | 9.6x | 6.6x | 9.0x |
| Current ratio | β | 1.5x | 1.8x | 2.2x | 2.4x |
| Quick ratio | β | 0.8x | 1.2x | 1.4x | 1.7x |
| Total assets | β | $867M | $1.1B | $1.2B | $1.4B |
| Total liabilities | β | $412M | $1.0B | $963M | $972M |
| Shareholders' equity | $428M | $456M | $80.7M | $227M | $379M |
| Net debt (β = net cash) | β | $0.0M | $433M | $410M | $336M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β |
| F-score | β / 3 | β / 5 | 5 / 9 | 5 / 9 | 6 / 9 |
| Accruals ratio | β | 0.5% | β1.8% | 7.0% | 0.4% |
| Altman Z'' | β | 4.02 | 3.79 | 4.74 | 5.54 |
5 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.4B | $1.6B | $1.6B | $1.7B | $1.8B |
| Gross profit | $349M | $359M | $433M | $462M | $498M |
| Research and development | $42.0M | $38.6M | $42.5M | $40.6M | $40.7M |
| Operating income | $214M | $204M | $248M | $266M | $299M |
| Interest expense | $0.8M | $0.7M | $25.8M | $40.6M | $33.4M |
| Pretax income | $217M | $212M | $226M | $235M | $266M |
| Income tax | $46.5M | $41.6M | $55.1M | $49.2M | $58.8M |
| Net income | $170M | $170M | $171M | $186M | $207M |
| Diluted EPS | $2.04 | $2.05 | $2.05 | $2.22 | $2.50 |
| Diluted shares | 0.08B | 0.08B | 0.08B | 0.08B | 0.08B |
| Cash flow | |||||
| Cash from operations | $210M | $166M | $189M | $105M | $203M |
| Capital expenditure | $33.4M | $37.5M | $45.8M | $48.6M | $53.9M |
| Free cash flow | $177M | $128M | $143M | $56.8M | $149M |
| Depreciation and amortization | $21.6M | $21.6M | $21.5M | $24.8M | $30.0M |
| Stock-based compensation | $0.0M | $0.0M | $7.2M | $11.9M | $12.4M |
| Share buybacks | β | $0.0M | $0.0M | $20.0M | $60.7M |
| Dividends and buybacks | β | $0.0M | $0.0M | $20.0M | $60.7M |
| Balance sheet | |||||
| Cash and short-term investments | $0.0M | $0.0M | $168M | $184M | $236M |
| Total debt | β | $0.0M | $600M | $593M | $570M |
| Finance lease liabilities | β | β | $0.8M | $1.5M | $2.1M |
| Current assets | β | $500M | $693M | $755M | $892M |
| Current liabilities | β | $331M | $375M | $345M | $368M |
| Inventory | β | $245M | $250M | $267M | $282M |
| Property and equipment, net | β | $148M | β | β | β |
| Goodwill | β | $84.7M | $84.7M | $84.7M | $84.7M |
| Intangible assets | β | β | β | β | $0.0M |
| Total assets | β | $867M | $1.1B | $1.2B | $1.4B |
| Total liabilities | β | $412M | $1.0B | $963M | $972M |
| Shareholders' equity | $428M | $456M | $80.7M | $227M | $379M |
| Margins | |||||
| Gross margin | 24.3% | 23.0% | 26.6% | 27.7% | 28.2% |
| Operating margin | 14.8% | 13.1% | 15.3% | 15.9% | 16.9% |
| EBITDA margin | 16.3% | 14.4% | 16.6% | 17.4% | 18.6% |
| Net margin | 11.8% | 10.9% | 10.5% | 11.1% | 11.8% |
| FCF margin | 12.3% | 8.2% | 8.8% | 3.4% | 8.4% |
| Returns | |||||
| Return on capital | β | 36.0% | 36.7% | 33.1% | 32.7% |
| Return on capital employed | β | 38.0% | 34.8% | 31.5% | 30.4% |
| Return on equity | 39.8% | 38.6% | 63.9% | 120.5% | 68.5% |
| Return on assets | β | 19.6% | 17.5% | 16.3% | 16.3% |
| Return on tangible equity | 39.8% | 45.9% | β | 130.1% | 70.6% |
| Growth | |||||
| Revenue growth | β | 8.6% | 4.2% | 2.5% | 5.7% |
| Net income growth | β | 0.2% | 0.5% | 8.3% | 11.7% |
| EPS growth | β | 0.5% | 0.0% | 8.3% | 12.6% |
| FCF growth | β | β27.4% | 11.7% | β60.3% | 162.0% |
| Share count change | β | 0.0% | 0.1% | 0.2% | β1.0% |
| Financial health | |||||
| Net debt / EBITDA | β | 0.0x | 1.6x | 1.4x | 1.0x |
| Debt / equity | β | 0.0x | 7.4x | 2.6x | 1.5x |
| Interest coverage | 266.9x | 291.3x | 9.6x | 6.6x | 9.0x |
| Current ratio | β | 1.5x | 1.8x | 2.2x | 2.4x |
| Quick ratio | β | 0.8x | 1.2x | 1.4x | 1.7x |
| Capital allocation | |||||
| Capex / revenue | 2.3% | 2.4% | 2.8% | 2.9% | 3.1% |
| Stock comp / revenue | 0.0% | 0.0% | 0.4% | 0.7% | 0.7% |
| Payouts / FCF | β | 0.0% | 0.0% | 35.2% | 40.8% |
| Quality scores | |||||
| Piotroski F-score | β | β | 5.0 | 5.0 | 6.0 |
| Altman Z'' | β | 4.0 | 3.8 | 4.7 | 5.5 |
| Accruals ratio | β | 0.5% | β1.8% | 7.0% | 0.4% |
Source: SEC EDGAR XBRL filings (CIK 0001921963). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.